IPSC - Century Therapeutics Inc

https://www.centurytx.com

Recent News

Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

GlobeNewswire • 3 weeks, 3 days ago • score: 0.39

PHILADELPHIA, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Century Therapeutics, Inc. ( 'Century', NASDAQ: IPSC ) , an innovative biotechnology company developing induced pluripotent stem cell ( iPSC ) -derived cell therapies in autoimmune disease and cancer, today announced that Brent Pfeiffenberger, ...

Bullish

Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - Century Therapeutics ( NASDAQ:IPSC )

Benzinga • 3 weeks, 3 days ago • score: 0.31

PHILADELPHIA, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Century Therapeutics, Inc. ( ( 'Century', NASDAQ:IPSC ) , an innovative biotechnology company developing induced pluripotent stem cell ( iPSC ) -derived cell therapies in autoimmune disease and cancer, today announced that Brent Pfeiffenberger, ...

Bullish

All You Need to Know About Century Therapeutics ( IPSC ) Rating Upgrade to Strong Buy

Zacks Commentary • 1 month, 3 weeks ago • score: 0.36

Century Therapeutics (IPSC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Bullish

Despite Fast-paced Momentum, Century Therapeutics ( IPSC ) Is Still a Bargain Stock

Zacks Commentary • 2 months ago • score: 0.42

Century Therapeutics (IPSC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Bullish

Century Therapeutics ( IPSC ) Is Attractively Priced Despite Fast-paced Momentum

Zacks Commentary • 2 months, 3 weeks ago • score: 0.43

Century Therapeutics (IPSC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Bullish

Fast-paced Momentum Stock Century Therapeutics ( IPSC ) Is Still Trading at a Bargain

Zacks Commentary • 3 months, 1 week ago • score: 0.47

Bullish

Century Therapeutics, Inc. ( IPSC ) Q1 Earnings and Revenues Top Estimates

Zacks Commentary • 3 months, 4 weeks ago • score: 0.16

Century Therapeutics (IPSC) delivered earnings and revenue surprises of 387.10% and 139.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

None

52W High

$1.86

52W Low

$0.34

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.78

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

0.08

EV/Revenue (<3 favorable)

1.96

P/S (TTM) (<3 favorable)

0.38

P/B (<3 favorable)

0.21

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

26.69%

Institutions (25–75% balanced)

41.94%

Shares Outstanding

86,389,000

Float

45,357,700

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

114,128,000

Gross Profit (TTM)

4,086,000

EPS (TTM)

-0.28

Profit Margin (>10% good)

-0.20%

Operating Margin (TTM) (higher better)

-0.25%

ROE (TTM) (>15% strong)

-0.11%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

126.68

Momentum

Value

N/A

Trend

—

Signal Cross

No cross

As of

—